December, 2007:

FDA to generics firms: OK to sell Zyrtec OTC

People News

Product News

UMass policy affects flow of education grants, samples

Wyeth sees generic threats, another delay on Viviant

Federal judge rejects Maine Rx data law

Zetia marketers never fully revealed liver risks: NY Times

GSK to shift consumer media business by end of Feb.

Plaintiff's Lipitor off-label case hinges on proving false claims

Company news

People News

Product news

NYU nixes controversial awareness ads on child psych ills

ACC to re-examine approach to satellite fees amid concern

As Pfizer acquires CovX and Coley buy clears, small deals are expected to continue

People news

Product news

FDA rejects Merck's Mevacor OTC bid

Lilly CEO Taurel to retire

Amgen's 'Dmab' in need of differentiation: analyst

FDA seeks more info on Cervarix

Saatchi Healthcare rebrands for more holistic approach

Company news

People news

Product news

Harte-Hanks revamps digital practice

Docs rate top specialty reps

Shire announces changes at the top

Novartis to implement additional job cuts: Vasella to WSJ

Advanstar launches portal for medical titles

Sweeneys to make room for new leadership at Dorland

Washington, DC, pharma sales rep licensing bill passes first vote

Doribax

Company news

People news

Reckitt Benckiser to acquire Adams for $2.3 billion

Corbett Accel taps Cooper-Broski as new EVP,CMO

Product News

Eisai in deal to acquire MGI Pharma for $3.9 billion

District of Columbia bill seeks to license sales reps

Company news

People News

Product news

Dossier offers one-stop shop for new drug insights

Pfizer and Adolor in pain drug pact

BMS confirms job cuts at investor meeting

Avastin setback could affect other cancer meds, analyst says

Revolution Health buys two online companies in battle to unseat WebMD

Novartis planning four new cancer drugs: Oncology president says

Company news

People news

Product news

Novartis in biotech partnership with MorphoSys

PhRMA spokesman snaps at teen reporter in Savannah

Waxman: FDA off-label reprint guidance on the way

BMS expected to announce job cuts at investor meeting

Masoudi rejoins FDA as new chief counsel

Lilly says labeling for Zyprexa and Symbyax reflects recent data

FDA approves labeling changes for ED drugs

The FDA cites CSL Behring LLC's DTC brochure

FDA creates pediatric review agency

Federal preemption fails in award against Wyeth products

Bill would kill drug market exclusivity

Drug ad violations rising, biologics numbers down

As I see it

inVentiv Commercial announces realignment of its business

RTCRM hires Brad Blackmon

Lois Smith joins MediZine

IMC names PDI's former president as its CEO

Sepracor, King to slash sales forces

Cegedim Dendrite enlists FDA expert

DDMAC to Scios: halt Natrecor promo

Merion rebrands Advance for Imagine & Oncology Administrators

PLoS launches online journal devoted to tropical diseases

HMP names Norton VP, meetings and trade shows

Thomson Scientific names Novartis number one company of 2007

Elsevier launches Clinical Solutions

Advanstar enlists Deal to lead MedEc

Novartis targets oncologists with blog

Pfizer pfudges with its withdrawal of Exubera

PR View by Gil Bashe

Does tracking Web traffic jam ads?

Headliner: Advertising Coalition's Jim Davidson

Pipeline 2008

Outlook 2008: Rubin's Rubric

Outlook 2008: Electile Dysfunction

You had to be there...

TNS quantifies Avandia cardiac toll

Emotional techniques build brands' personality

Vantage Point

ACCME firewall letter sent, but not sealed

WebMD, Yahoo! sign exclusive deal

Google's health initiative expected to launch in '08

Web Watch

CME LLC is exclusive provider of psychiatric CME content for ReachMD

Ray Wolf joins Sepracor

60% of med school chairs have formed relationship with industry

Task force audience members don't support pooled fund CME activities

PhRMA working on CME guidance

DDMAC asks companies to notify FDA if they participate in DTC program

Lunesta moth still most-recalled drug ad

BMS says spend increased by 23% in Q3

Edwards calls for moratorium on TV ads for new drugs

J&J seeks to boost stent with DTC ads

Credentialers take another step

Pfizer set to take CME in new direction

The certainty of uncertainty

Plus ça change....

Antidote

Guidance issued on joint sponsorship